{"id":8884,"date":"2024-05-28T10:58:11","date_gmt":"2024-05-28T08:58:11","guid":{"rendered":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg"},"modified":"2025-01-22T10:50:45","modified_gmt":"2025-01-22T09:50:45","slug":"10_104270789-150x150-3-2","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/maat-pharma-announces-positive-second-dsmb-review-of-ongoing-phase-2b-clinical-trial-evaluating-maat033-for-patients-receiving-allo-hsct\/10_104270789-150x150-3-2\/","title":{"rendered":"10_104270789-150&#215;150"},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-8884","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>10_104270789-150x150 | Seventure<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg\",\"url\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg\",\"name\":\"10_104270789-150x150 | Seventure\",\"isPartOf\":{\"@id\":\"https:\/\/www.seventure.fr\/en\/#website\"},\"datePublished\":\"2024-05-28T08:58:11+00:00\",\"dateModified\":\"2025-01-22T09:50:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.seventure.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MaaT Pharma Announces Positive Second DSMB Review of Ongoing Phase 2b Clinical Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT\",\"item\":\"https:\/\/www.seventure.fr\/en\/maat-pharma-announces-positive-second-dsmb-review-of-ongoing-phase-2b-clinical-trial-evaluating-maat033-for-patients-receiving-allo-hsct\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"10_104270789-150&#215;150\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.seventure.fr\/en\/#website\",\"url\":\"https:\/\/www.seventure.fr\/en\/\",\"name\":\"Seventure\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.seventure.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"10_104270789-150x150 | Seventure","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg","url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg","name":"10_104270789-150x150 | Seventure","isPartOf":{"@id":"https:\/\/www.seventure.fr\/en\/#website"},"datePublished":"2024-05-28T08:58:11+00:00","dateModified":"2025-01-22T09:50:45+00:00","breadcrumb":{"@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.seventure.fr\/en\/"},{"@type":"ListItem","position":2,"name":"MaaT Pharma Announces Positive Second DSMB Review of Ongoing Phase 2b Clinical Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT","item":"https:\/\/www.seventure.fr\/en\/maat-pharma-announces-positive-second-dsmb-review-of-ongoing-phase-2b-clinical-trial-evaluating-maat033-for-patients-receiving-allo-hsct\/"},{"@type":"ListItem","position":3,"name":"10_104270789-150&#215;150"}]},{"@type":"WebSite","@id":"https:\/\/www.seventure.fr\/en\/#website","url":"https:\/\/www.seventure.fr\/en\/","name":"Seventure","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seventure.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg 150w, https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3-44x44.jpg 44w, https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3-24x24.jpg 24w, https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3-50x50.jpg 50w, https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3-70x70.jpg 70w, https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3-85x85.jpg 85w\" sizes=\"auto, (max-width: 150px) 85vw, 150px\" \/><\/a><\/p>\n"},"caption":{"rendered":""},"alt_text":"","media_type":"image","mime_type":"image\/jpeg","media_details":{"width":150,"height":150,"file":"2024\/05\/10_104270789-150x150-3.jpg","filesize":6652,"sizes":{"chiffres-home":{"file":"10_104270789-150x150-3-44x44.jpg","width":44,"height":44,"filesize":1252,"mime_type":"image\/jpeg","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3-44x44.jpg"},"sector-picto":{"file":"10_104270789-150x150-3-24x24.jpg","width":24,"height":24,"filesize":635,"mime_type":"image\/jpeg","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3-24x24.jpg"},"list-team":{"file":"10_104270789-150x150-3-50x50.jpg","width":50,"height":50,"filesize":1554,"mime_type":"image\/jpeg","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3-50x50.jpg"},"logo-partners-team":{"file":"10_104270789-150x150-3-70x70.jpg","width":70,"height":70,"filesize":2225,"mime_type":"image\/jpeg","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3-70x70.jpg"},"country-flag":{"file":"10_104270789-150x150-3-31x21.jpg","width":31,"height":21,"filesize":684,"mime_type":"image\/jpeg","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3-31x21.jpg"},"logo-home":{"file":"10_104270789-150x150-3-85x85.jpg","width":85,"height":85,"filesize":2901,"mime_type":"image\/jpeg","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3-85x85.jpg"},"full":{"file":"10_104270789-150x150-3.jpg","width":150,"height":150,"mime_type":"image\/jpeg","source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg"}},"image_meta":{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"1","keywords":[]}},"post":9381,"source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/05\/10_104270789-150x150-3.jpg","_links":{"self":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media\/8884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/comments?post=8884"}]}}